Properties (53)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
Acquired_by_RPG_Enterprises_in_2000
|
gptkbp:awards |
Best Employer Award 2019
Excellence in R&D 2020 Best_Pharmaceutical_Company_2021 |
gptkbp:CEO |
gptkb:Ravi_Kumar
|
gptkbp:certifications |
gptkb:ISO_9001
gptkb:WHO_GMP |
gptkbp:collaborations |
Government Agencies
Academic Institutions Research Organizations |
gptkbp:communityInvolvement |
Educational Programs
Environmental Initiatives Health Camps |
gptkbp:employees |
Over 1000
|
gptkbp:exportMarkets |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Africa Europe |
gptkbp:focus |
Research_and_Development
|
gptkbp:founded |
1993
|
gptkbp:futurePlans |
Expansion into New Markets
Increase R&D Budget Launch_New_Products Enhance_Digital_Capabilities |
gptkbp:headquarters |
gptkb:Mumbai,_India
|
https://www.w3.org/2000/01/rdf-schema#label |
RPG Life Sciences Limited
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:investmentFocus |
R&D Expansion 2023
Technology Upgrades 2021 New_Manufacturing_Facility_2022 |
gptkbp:market |
Global
|
gptkbp:parentCompany |
gptkb:RPG_Enterprises
|
gptkbp:partnerships |
Various global pharmaceutical companies
|
gptkbp:products |
Formulations
Active_Pharmaceutical_Ingredients |
gptkbp:researchAreas |
Cardiology
Oncology Diabetes Neurology Infectious Diseases |
gptkbp:revenue |
Approximately $100 million
|
gptkbp:services |
Clinical Trials
Quality Control Regulatory Affairs Contract Manufacturing |
gptkbp:subsidiary |
gptkb:RPG_Life_Sciences_USA
|
gptkbp:sustainabilityInitiatives |
Waste Management Programs
Energy Efficiency Projects Water Conservation Efforts Sustainable Sourcing Practices |
gptkbp:website |
www.rpglifesciences.com
|